Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 23.51M P/E - EPS this Y 15.80% Ern Qtrly Grth -
Income -35.04M Forward P/E -1.15 EPS next Y 54.90% 50D Avg Chg -7.00%
Sales 7.1M PEG - EPS past 5Y - 200D Avg Chg -34.00%
Dividend N/A Price/Book 2.37 EPS next 5Y - 52W High Chg -79.00%
Recommedations 1.70 Quick Ratio 1.06 Shares Outstanding 16.14M 52W Low Chg 12.00%
Insider Own 3.35% ROA -84.77% Shares Float 15.54M Beta 0.89
Inst Own 10.73% ROE -1,413.30% Shares Shorted/Prior 1.46M/1.16M Price 2.04
Gross Margin -225.96% Profit Margin - Avg. Volume 54,282 Target Price 9.33
Oper. Margin -326.94% Earnings Date May 14 Volume 45,282 Change -4.67%
About Palatin Technologies, Inc.

Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that is in Phase 2 clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease, which is in Phase 3 clinical trial; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL8177, an oral peptide formulation for treatment of ulcerative colitis, which entered Phase 2 clinical trials. The company was founded in 1986 and is based in Cranbury, New Jersey.

Palatin Technologies, Inc. News
04/14/24 10 Micro-Cap Healthcare Stocks Insiders Are Buying
04/09/24 Palatin (PTN) Up 15% on Results From Dry Eye Disease Study
04/08/24 Palatin Technologies Eyes Growing $6B Dry Eye Disease Market With Late-Stage Study Data
04/08/24 Palatin Announces Phase 3 PL9643 MELODY-1 Dry Eye Disease (DED) Clinical Data Results Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2024
02/28/24 Palatin Announces Results of PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED)
02/16/24 Palatin Technologies, Inc. (AMEX:PTN) Q2 2024 Earnings Call Transcript
02/16/24 Q2 2024 Palatin Technologies Inc Earnings Call
02/15/24 Palatin Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
02/09/24 Palatin to Report Second Quarter Fiscal Year 2024 Results; Teleconference and Webcast to be held on February 15, 2024
02/05/24 Palatin Announces Database Lock for PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED)
02/01/24 Palatin Announces Closing of $10 Million Registered Direct Offering
01/30/24 Palatin Announces $10 Million Registered Direct Offering
01/29/24 Strength Seen in Repligen (RGEN): Can Its 4.3% Jump Turn into More Strength?
01/11/24 3 Penny Stocks to Buy to Unlock 2,500% Upside Potential
01/08/24 Palatin Provides Corporate Update and Highlights Strategic Priorities for Calendar Year 2024
01/03/24 Cosette Pharmaceuticals Acquires Vyleesi® (Bremelanotide Injection) from Palatin Technologies Inc.
12/23/23 Analysts Say 3 Stocks Have a Combined Upside of 3000%
12/20/23 Palatin Completes Sale of Vyleesi® to Cosette Pharmaceuticals for up to $171 Million
12/18/23 Palatin Receives Notice of Acceptance of the Listing Standards Compliance Plan from NYSE American
11/15/23 Palatin Technologies, Inc. (AMEX:PTN) Q1 2024 Earnings Call Transcript
PTN Chatroom

User Image Ulong Posted - 20 hours ago

$PTN Impressive pipeline. News coming in Q2 and H2 2024📈 https://palatin.com/pipeline

User Image RallyRaider Posted - 1 day ago

$PTN is one to take a deeper look at. Great bar a few days ago on data

User Image samuelp Posted - 1 day ago

$PTN Down baby! Down Baby! Hump! Hump! Hump!

User Image palatintech Posted - 2 days ago

$PTN 🚀More Exciting News from Palatin Technologies! 🚀 We're thrilled to announce positive results from our Phase 3 PL9643 MELODY-1 clinical trial for Dry Eye Disease, showcased at the ASCRS 2024. 🌟 Key Highlights:🔹 The co-primary symptom endpoint of pain met statistical significance. 🔹Rapid onset of efficacy was observed within just two weeks. 🔹Outstanding safety and tolerability profile. These results underscore PL9643's potential in transforming DED treatment and position us at the forefront of ophthalmic innovation. 🌐 Dive into the full details of our positive phase 3 results here. https://bit.ly/4aTSGhe

User Image josegodoy Posted - 2 days ago

$PTN interesting

User Image Ziebof Posted - 2 days ago

$PTN people try to get the stock down, but it will only go up.

User Image Tpharma Posted - 3 days ago

$PTN Hard to believe that palatin has no approved drugs but still a higher market cap than $EYEN right now. Granted thay Eyenovia need cash, but they have two FDA approved products and also Micropine, a unique and important drug in P3 trials at the moment. If you like cheap stocks then it’s certainly worth the gamble at this price.

User Image braves1983 Posted - 3 days ago

$PTN why did it just drop and crash like that? what a waste of a day. it was green all day.

User Image RunningRobert1 Posted - 3 days ago

$PTN Palatin Technologies Inc PTN P3 Results Summary Did they pass or fail? 15Apr2024' https://youtu.be/QJRO8_W1eiU A summary about last weeks news, and looking at what PTN is trying to do, I do not have any warm and fuzzy about how they are trying to frame the data

User Image Vickyoko Posted - 3 days ago

$PTN $VTGN $ATOS $NKTR

User Image Iwillbuy Posted - 3 days ago

$PTN I warned you guys this company is and has been run by decades long scammers! Don’t loose your money to them!

User Image Tpharma Posted - 4 days ago

$PTN Read the terms of the milestone payments. Palatin do not get royalties from each unit sold, they only receive money when Cosette hit certain numbers. If you had done the due diligence before, then you would know this. I was invested in this for 3 years and pulled my money out after the mediocre P3 result for a small loss. I won’t be investing in PTN until end of Q3.

User Image Ziebof Posted - 4 days ago

$PTN Will not need an offering since they have milestone income for vyleesi (Cosette is on the hook for $159 million in contingent, sales-based milestones). No worries here this will only go up!

User Image Tpharma Posted - 5 days ago

$PTN I’m not saying there won’t be a further pump n dump before the next offering, there might be. But I don’t invest for pump n dumps, I’m not currently in this stock at the moment. I am looking at the timeline, the next news catalyst for this stock is the UC P2 results in Q4, followed by the start of MELODY2 in 2025. The company needs to do an offering before the end of Q3, so the price will dip a lot as the end of Q3 looms. Better to pull money out now (or would’ve been best at the peak of the latest pump n dump at $2.80, then reinvest at end of Q3, just after the offering. Check out $EYEN if you want to see a bargain. They are low on cash and looking to sell or partner, but they have two FDA approved products already and a very important drug in P3 trials currently. At $0.53 it’s a very low level for a stock with such high potential. Always do due diligence first though

User Image HippoCritical Posted - 6 days ago

$PTN if it's not tanking on a bloody day something is cooking, maybe one more pump before an offering. Tpharma said it won't tho

User Image DayWarlock Posted - 6 days ago

$PTN $VTVT $DJT 🤷🏻‍♂️🤠 anyone down? 🤣🤷🏻‍♂️

User Image Vickyoko Posted - 6 days ago

$PTN

User Image Stocksrunner Posted - 6 days ago

Insider activity roundup: $VOD - GQG and SBI funds eye $2.16B investment in Vodafone Idea. $PTN - Insiders at Palatin Technologies are buying. $BBY - Insiders at Best Buy are selling. $AAPL - One investor has sold all their Apple shares. Stay informed on the latest insider moves as you navigate the markets. https://stocksrunner.com/insiders

User Image braves1983 Posted - 6 days ago

$PTN up and then down.

User Image insiderbuyingselling Posted - 1 week ago

$PTN new insider buying: 6000 shares. http://insiderbuyingselling.com/?t=PTN

User Image JOHNB21400 Posted - 1 week ago

$PTN I liked the twelve million share day on Monday. It showed interest in the company. We should do that again when the DED is submitted to the FDA.

User Image AHHunter Posted - 1 week ago

$PTN Just to complete the nice posting beneath this one. "Stay ahead of biotech stocks seeing a surge in interest from retail and financial professional investors with this exclusive recap from The Fly "These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: " "Palatin Technologies (PTN), 1,002% surge in interest Leap Therapeutics (LPTX), 226% surge in interest Brainstorm Cell (BCLI), 215% surge in interest Cassava Sciences (SAVA), 212% surge in interest Eyenovia (EYEN), 211% surge in interest Cue Biopharma (CUE), 141% surge in interest Molecular Templates (MTEM), 120% surge in interest VBI Vaccines (VBIV), 114% surge in interest Syros Pharmaceuticals (SYRS), 109% surge in interest Alkermes (ALKS), 106% surge in interest"

User Image theflynews Posted - 1 week ago

Biotech Alert: Searches spiking for these stocks today - $PTN - https://thefly.com/permalinks/entry.php/PTNid3895837

User Image Tpharma Posted - 1 week ago

$PTN There are no news catalysts this time round before they run out of cash at the end of Q3. There UC P2 readout is in Q4. Congrats if you profited from the latest pump and dump, it was a chance for people to sell out of this stock before the decline. The selling was today (the first part of the dump). Do not get dragged in by hype. This stock is good for a pump and dump AND also after the dilution that they will he forced to do, in run up to UC P2 results.

User Image Vickyoko Posted - 1 week ago

$PTN would be nice if it closed above 1.9 at least

User Image HippoCritical Posted - 1 week ago

$PTN what a surprise 🫢 noot

User Image braves1983 Posted - 1 week ago

$PTN why the fuck did this just 30 cents

User Image braves1983 Posted - 1 week ago

$PTN why why why ....

User Image LDio Posted - 1 week ago

$PTN Hot inflation numbers pushing this down. Still I've never understood why everyone thinks rates are going down to begin with I think they should be probably going up anyway I guess we'll see.

User Image theflynews Posted - 1 week ago

Biotech Alert: Searches spiking for these stocks today - $PTN - https://thefly.com/permalinks/entry.php/PTNid3895089

Analyst Ratings
HC Wainwright & Co. Buy Feb 28, 24
HC Wainwright & Co. Buy Feb 15, 24
HC Wainwright & Co. Buy Aug 10, 23
HC Wainwright & Co. Buy Aug 8, 23
HC Wainwright & Co. Buy Aug 7, 23
HC Wainwright & Co. Buy May 30, 23
HC Wainwright & Co. Buy May 9, 23
HC Wainwright & Co. Buy Mar 13, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
WILLS STEPHEN T Executive VP and CFO.. Executive VP and CFO/COO Dec 06 Sell 2.53 4,998 12,645 327,522 12/08/23
DUNTON ALAN W Director Director Dec 04 Sell 2.47 200 494 45,074 12/06/23
SPANA CARL President and CEO President and CEO Dec 27 Buy 2.23 10,000 22,300 293,604 12/28/22
WILLS STEPHEN T Executive VP and CFO.. Executive VP and CFO/COO Dec 27 Buy 2.22 10,000 22,200 267,101 12/28/22
DUNTON ALAN W Director Director Dec 21 Sell 2.97 200 594 41,420 12/23/22